1. Home
  2. VIR vs CMP Comparison

VIR vs CMP Comparison

Compare VIR & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • CMP
  • Stock Information
  • Founded
  • VIR 2016
  • CMP 1993
  • Country
  • VIR United States
  • CMP United States
  • Employees
  • VIR N/A
  • CMP N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • CMP Other Metals and Minerals
  • Sector
  • VIR Health Care
  • CMP Basic Materials
  • Exchange
  • VIR Nasdaq
  • CMP Nasdaq
  • Market Cap
  • VIR 706.4M
  • CMP 781.2M
  • IPO Year
  • VIR 2019
  • CMP 2003
  • Fundamental
  • Price
  • VIR $4.80
  • CMP $17.92
  • Analyst Decision
  • VIR Strong Buy
  • CMP Hold
  • Analyst Count
  • VIR 11
  • CMP 3
  • Target Price
  • VIR $25.73
  • CMP $20.00
  • AVG Volume (30 Days)
  • VIR 1.5M
  • CMP 325.1K
  • Earning Date
  • VIR 10-30-2025
  • CMP 08-11-2025
  • Dividend Yield
  • VIR N/A
  • CMP N/A
  • EPS Growth
  • VIR N/A
  • CMP N/A
  • EPS
  • VIR N/A
  • CMP N/A
  • Revenue
  • VIR $19,000,000.00
  • CMP $1,225,200,000.00
  • Revenue This Year
  • VIR N/A
  • CMP $12.05
  • Revenue Next Year
  • VIR $11.08
  • CMP $4.15
  • P/E Ratio
  • VIR N/A
  • CMP N/A
  • Revenue Growth
  • VIR N/A
  • CMP 7.27
  • 52 Week Low
  • VIR $4.16
  • CMP $8.60
  • 52 Week High
  • VIR $14.45
  • CMP $22.69
  • Technical
  • Relative Strength Index (RSI)
  • VIR 46.19
  • CMP 37.16
  • Support Level
  • VIR $4.75
  • CMP $17.90
  • Resistance Level
  • VIR $5.39
  • CMP $18.82
  • Average True Range (ATR)
  • VIR 0.30
  • CMP 0.64
  • MACD
  • VIR -0.02
  • CMP -0.04
  • Stochastic Oscillator
  • VIR 5.63
  • CMP 3.59

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

Share on Social Networks: